Drug survival and safety in chronic urticaria: comparative analysis of omalizumab and antihistamines

Cutaneous and Ocular Toxicology · Published 2026-03-06 · DOI 10.1080/15569527.2026.2638833

Authors being retrieved — see the publisher record. https://doi.org/10.1080/15569527.2026.2638833

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Resina draconis extract improves wound healing in rats with laser burn · Cutaneous and Ocular Toxicology · 2026 · Same journal
• Dermal hyperpigmentation: pathogenesis, biomarkers and translational safety considerations for emerging therapies · Cutaneous and Ocular Toxicology · 2026 · Same journal
• Efficacy of shortwave radiofrequency-assisted delivery of Quhong Zhiyang ointment in the treatment of facial seborrheic dermatitis: a retrospective study of 72 patients · Cutaneous and Ocular Toxicology · 2026 · Same journal
• Metal concentration analysis and dermal exposure risk modeling of heavy metal impurities in cosmetics products marketed in Seoul, Korea · Cutaneous and Ocular Toxicology · 2026 · Same journal
• Audio-vestibular abnormalities in patients with rosacea: a prospective case-control study · Cutaneous and Ocular Toxicology · 2026 · Same journal
• Kaposi’s sarcoma in individuals living with HIV: comparative assessment of AI-based clinical responses using a standardized questionnaire set · Cutaneous and Ocular Toxicology · 2026 · Same journal
• A silent epidemic: five-year study on methanol poisoning and its ocular aftermath (2018–2022) · Cutaneous and Ocular Toxicology · 2026 · Same journal
• Antiproliferative and proapoptotic effects of Dalbergia odorifera flavonoids in cSCC · Cutaneous and Ocular Toxicology · 2026 · Same journal
• Investigation of systemic inflammatory biomarkers associated with high-density lipoprotein and risk analysis in Xanthelasma Palpebrarum · Cutaneous and Ocular Toxicology · 2026 · Same journal
• Examining the association of dipeptidyl peptidase-4 inhibitors with autoimmune blistering disorders in the U.S. Military veterans · Cutaneous and Ocular Toxicology · 2026 · Same journal